Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Framingham Heart Study
100%
Middle-aged Adults
100%
Liver Fibrosis
100%
Tau Pathology
100%
Amyloid Pathology
100%
Fibrosis-4 (FIB-4)
85%
Advanced Fibrosis
28%
Inferior Temporal
28%
Alzheimer's Disease Pathology
28%
Tau Positron Emission Tomography
28%
Potential Confounders
14%
Health Condition
14%
Parahippocampal Region
14%
Offspring Generation
14%
Non-associated
14%
Abdomen
14%
Risk Factors
14%
Liver Steatosis
14%
Parahippocampal Gyrus
14%
Computed Tomography
14%
Cardiometabolic Risk
14%
Third Generation
14%
Linear Regression Model
14%
Generation Cohort
14%
Positron Emission Tomography
14%
Disease Information
14%
Amyloid beta
14%
Multiple Comparisons
14%
Temporal Region
14%
Entorhinal
14%
Background Liver
14%
18F-flortaucipir
14%
Brain Amyloid
14%
Pittsburgh Compound B
14%
Early Alzheimer's Disease
14%
Noninvasive Index
14%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Liver Fibrosis
100%
Middle Age
100%
Tau
100%
Amyloid Protein
100%
Focused Ion Beam
85%
Fibrosis
28%
Alzheimer's Disease
28%
Positron Emission Tomography
28%
Fatty Liver
14%
Computer Assisted Tomography
14%
Cardiometabolic Risk
14%
Linear Regression Analysis
14%
Parahippocampal Gyrus
14%
Fluorine-18
14%
Carbon 11
14%
Flortaucipir
14%
Study Participant
14%
Pittsburgh Compound B
14%
Offspring
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Liver Fibrosis
100%
Amyloid Protein
100%
Focused Ion Beam
85%
Fibrosis
28%
Alzheimer's Disease
28%
Fatty Liver
14%
Carbon 11
14%
Fluorine 18
14%
Pittsburgh Compound B
14%
Flortaucipir
14%
Neuroscience
Amyloid Protein
100%
Alzheimer's Disease
66%
Positron Emission Tomography
66%
Computed Tomography
33%
Fluorine-18
33%
Parahippocampal Gyrus
33%